title: Shiga toxins: from structure and mechanism to applications.
abstract: Shiga toxins are a group of type 2 ribosome-inactivating proteins (RIPs) produced in several types of bacteria. The toxins possess an AB5 structure, which comprises a catalytic A chain with N-glycosidase activity, and five identical B chains and recognize and bind to the target cells with specific carbohydrate moieties. In humans, the major molecular target which recognizes the Shiga toxins is the Gb3 receptor, which is mainly expressed on the cell surface of endothelial cells of the intestine, kidney, and the brain. This causes these organs to be susceptible to the toxicity of Shiga toxins. When a person is infected by Shiga toxin-producing bacteria, the toxin is produced in the gut, translocated to the circulatory system, and carried to the target cells. Toxicity of the toxin causes inflammatory responses and severe cell damages in the intestine, kidneys, and brain, bringing about the hemolytic uremic syndrome (HUS), which can be fatal. The Shiga toxin requires a couple of steps to exert its toxicity to the target cells. After binding with the target cell surface receptor, the toxin requires a complicated process to be transported into the cytosol of the cell before it can approach the ribosomes. The mechanisms for the interactions of the toxin with the cells are described in this review. The consequences of the toxin on the cells are also discussed. It gives an overview of the steps for the toxin to be produced and transported, expression of catalytic activity, and the effects of the toxin on the target cells, as well as effects on the human body.
authors.affiliation: School of Biomedical Sciences, Lo Kwee Seong Integrated Biomedical Sciences Building, Faculty of Medicine, The Chinese University of Hong Kong, Shatin, New Territories, Hong Kong, China. bomberharo@yahoo.com.hk.
authors.forename: Yau Sang
authors.initials: YS
authors.lastname: Chan
authors.affiliation: School of Biomedical Sciences, Lo Kwee Seong Integrated Biomedical Sciences Building, Faculty of Medicine, The Chinese University of Hong Kong, Shatin, New Territories, Hong Kong, China. b021770@mailserv.cuhk.edu.hk.
authors.forename: Tzi Bun
authors.initials: TB
authors.lastname: Ng
mesh_terms: D001921:Brain / Q000187:drug effects / Q000473:pathology; D042783:Endothelial Cells / Q000187:drug effects; D005915:Globosides / Q000378:metabolism*; D006801:Humans; D007422:Intestines / Q000187:drug effects / Q000473:pathology; D007668:Kidney / Q000187:drug effects / Q000473:pathology; D011500:Protein Synthesis Inhibitors / Q000737:chemistry / Q000378:metabolism* / Q000633:toxicity*; D021381:Protein Transport; D012270:Ribosomes / Q000187:drug effects; D022603:Shiga Toxins / Q000737:chemistry / Q000378:metabolism* / Q000633:toxicity*; D014281:Trihexosylceramides / Q000378:metabolism*
chemical_list: D005915:Globosides; D011500:Protein Synthesis Inhibitors; D022603:Shiga Toxins; D014281:Trihexosylceramides; C514780:globotrihexosylceramide
keywords: Mechanism; Shiga; Structure; Toxicity